1 month Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Rating of “Moderate Buy” by BrokeragesMarketBeat
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-four research firms that are covering the stock, MarketBeat reports. Six analysts have rated the stock with a ho…
Nasdaq 100 · Pharmaceuticals · Science
X